Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nephrotic Syndrome | 21 | 2023 | 389 | 6.150 |
Why?
|
Glomerulosclerosis, Focal Segmental | 13 | 2023 | 359 | 3.670 |
Why?
|
Kidney Glomerulus | 6 | 2021 | 697 | 1.480 |
Why?
|
Genomics | 11 | 2023 | 5692 | 1.330 |
Why?
|
Urinary Tract | 5 | 2019 | 308 | 1.110 |
Why?
|
Kidney Diseases | 7 | 2023 | 2145 | 1.100 |
Why?
|
Kidney | 13 | 2023 | 7167 | 0.930 |
Why?
|
Genome-Wide Association Study | 15 | 2023 | 12220 | 0.850 |
Why?
|
Alleles | 11 | 2021 | 6931 | 0.840 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2023 | 2195 | 0.750 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2019 | 44 | 0.710 |
Why?
|
Nephrology | 2 | 2020 | 260 | 0.680 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2019 | 220 | 0.620 |
Why?
|
Genetic Testing | 4 | 2020 | 3439 | 0.570 |
Why?
|
Access to Information | 1 | 2019 | 320 | 0.550 |
Why?
|
Podocytes | 4 | 2021 | 394 | 0.550 |
Why?
|
Apolipoproteins | 2 | 2023 | 315 | 0.490 |
Why?
|
Genetics, Population | 2 | 2015 | 933 | 0.450 |
Why?
|
Kidney Tubules | 1 | 2015 | 486 | 0.450 |
Why?
|
Quantitative Trait Loci | 4 | 2022 | 2015 | 0.450 |
Why?
|
Genotype | 14 | 2023 | 12946 | 0.440 |
Why?
|
Genetic Variation | 6 | 2021 | 6540 | 0.410 |
Why?
|
Polymorphism, Single Nucleotide | 14 | 2023 | 15494 | 0.400 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 637 | 0.380 |
Why?
|
Microfluidics | 1 | 2016 | 662 | 0.380 |
Why?
|
Premature Birth | 2 | 2023 | 1713 | 0.360 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2010 | 355 | 0.330 |
Why?
|
Hirschsprung Disease | 1 | 2010 | 155 | 0.330 |
Why?
|
Selection, Genetic | 1 | 2013 | 914 | 0.330 |
Why?
|
Nephrosis, Lipoid | 2 | 2021 | 51 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 12 | 2023 | 17400 | 0.310 |
Why?
|
Sequence Deletion | 2 | 2015 | 1526 | 0.290 |
Why?
|
Proteinuria | 4 | 2023 | 657 | 0.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3585 | 0.290 |
Why?
|
Haplotypes | 4 | 2023 | 2781 | 0.290 |
Why?
|
Software | 3 | 2020 | 4434 | 0.270 |
Why?
|
Ubiquitins | 2 | 2018 | 383 | 0.250 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 1940 | 0.240 |
Why?
|
Child | 18 | 2023 | 77478 | 0.230 |
Why?
|
Glomerulonephritis | 2 | 2018 | 372 | 0.230 |
Why?
|
Humans | 55 | 2023 | 742088 | 0.220 |
Why?
|
Bayes Theorem | 2 | 2023 | 2303 | 0.220 |
Why?
|
Glomerular Filtration Rate | 4 | 2019 | 2167 | 0.210 |
Why?
|
Chromatin | 2 | 2023 | 2917 | 0.190 |
Why?
|
Phenotype | 8 | 2018 | 16331 | 0.190 |
Why?
|
Glomerulonephritis, Membranous | 2 | 2020 | 86 | 0.190 |
Why?
|
Adenosine Deaminase | 1 | 2022 | 241 | 0.190 |
Why?
|
Age of Onset | 2 | 2017 | 3266 | 0.180 |
Why?
|
Angiogenic Proteins | 1 | 2019 | 104 | 0.170 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2022 | 794 | 0.170 |
Why?
|
Kidney Failure, Chronic | 3 | 2022 | 2536 | 0.170 |
Why?
|
Membrane Proteins | 6 | 2021 | 7873 | 0.160 |
Why?
|
Urogenital Abnormalities | 2 | 2018 | 261 | 0.160 |
Why?
|
Interferon Type I | 1 | 2022 | 542 | 0.160 |
Why?
|
HLA-DQ Antigens | 1 | 2018 | 210 | 0.160 |
Why?
|
Genetics, Medical | 1 | 2020 | 337 | 0.150 |
Why?
|
Diacylglycerol Kinase | 1 | 2017 | 48 | 0.150 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2017 | 41 | 0.150 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2019 | 2915 | 0.150 |
Why?
|
Steroids | 2 | 2020 | 931 | 0.140 |
Why?
|
HLA-DR Antigens | 1 | 2018 | 644 | 0.140 |
Why?
|
Adolescent | 10 | 2023 | 85649 | 0.140 |
Why?
|
Vesicular Transport Proteins | 1 | 2019 | 377 | 0.140 |
Why?
|
PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2015 | 17 | 0.140 |
Why?
|
Chemokine CXCL11 | 1 | 2015 | 42 | 0.130 |
Why?
|
Chromosome Deletion | 2 | 2018 | 1400 | 0.130 |
Why?
|
Sequence Analysis, DNA | 5 | 2022 | 4801 | 0.130 |
Why?
|
Chemokine CXCL9 | 1 | 2015 | 132 | 0.130 |
Why?
|
Young Adult | 7 | 2023 | 56350 | 0.130 |
Why?
|
DiGeorge Syndrome | 1 | 2017 | 177 | 0.130 |
Why?
|
Genetic Association Studies | 4 | 2019 | 2699 | 0.130 |
Why?
|
Haploinsufficiency | 1 | 2017 | 329 | 0.130 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2018 | 427 | 0.130 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 944 | 0.120 |
Why?
|
Case-Control Studies | 8 | 2020 | 21719 | 0.120 |
Why?
|
RNA Splice Sites | 1 | 2015 | 209 | 0.120 |
Why?
|
Pedigree | 2 | 2019 | 4646 | 0.120 |
Why?
|
Cohort Studies | 9 | 2023 | 40450 | 0.120 |
Why?
|
Adult | 14 | 2023 | 213712 | 0.110 |
Why?
|
Child, Preschool | 6 | 2021 | 40955 | 0.110 |
Why?
|
Fetal Development | 1 | 2019 | 767 | 0.110 |
Why?
|
Risk Factors | 8 | 2023 | 72145 | 0.110 |
Why?
|
Autoantibodies | 1 | 2021 | 2036 | 0.110 |
Why?
|
Epidermal Growth Factor | 1 | 2015 | 709 | 0.110 |
Why?
|
Congenital Abnormalities | 1 | 2017 | 707 | 0.110 |
Why?
|
Introns | 1 | 2015 | 991 | 0.110 |
Why?
|
HEK293 Cells | 1 | 2021 | 4200 | 0.110 |
Why?
|
Reference Values | 2 | 2016 | 4982 | 0.110 |
Why?
|
Mucins | 1 | 2015 | 564 | 0.100 |
Why?
|
Female | 20 | 2023 | 379592 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2023 | 25575 | 0.100 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 370 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2751 | 0.100 |
Why?
|
Biopsy | 4 | 2015 | 6756 | 0.100 |
Why?
|
Genes, Recessive | 1 | 2013 | 642 | 0.100 |
Why?
|
Atrophy | 1 | 2015 | 1576 | 0.090 |
Why?
|
Rare Diseases | 1 | 2015 | 554 | 0.090 |
Why?
|
Ear | 1 | 2010 | 173 | 0.090 |
Why?
|
Point Mutation | 1 | 2015 | 1624 | 0.090 |
Why?
|
Mutation | 4 | 2020 | 29717 | 0.090 |
Why?
|
Gene Frequency | 1 | 2016 | 3587 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2572 | 0.090 |
Why?
|
Male | 18 | 2022 | 349538 | 0.090 |
Why?
|
Exons | 1 | 2015 | 2431 | 0.090 |
Why?
|
Fibrosis | 1 | 2015 | 2026 | 0.080 |
Why?
|
Prognosis | 5 | 2020 | 29010 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2016 | 2556 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2013 | 1780 | 0.070 |
Why?
|
Internet | 2 | 2016 | 3062 | 0.070 |
Why?
|
Graft Rejection | 1 | 2019 | 4393 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15056 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2022 | 19862 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9410 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2861 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3691 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2022 | 13029 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9679 | 0.060 |
Why?
|
Middle Aged | 6 | 2018 | 213127 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4246 | 0.060 |
Why?
|
Neptune | 1 | 2023 | 2 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3306 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12958 | 0.060 |
Why?
|
DNA Mutational Analysis | 3 | 2017 | 4187 | 0.060 |
Why?
|
Alternative Splicing | 2 | 2021 | 1118 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2019 | 4566 | 0.050 |
Why?
|
Zebrafish | 3 | 2019 | 2990 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7790 | 0.050 |
Why?
|
Inosine | 1 | 2022 | 133 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5851 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.050 |
Why?
|
RNA Editing | 1 | 2022 | 148 | 0.050 |
Why?
|
RNA, Double-Stranded | 1 | 2022 | 289 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8455 | 0.050 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 13 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2022 | 508 | 0.050 |
Why?
|
Genome, Human | 1 | 2013 | 4420 | 0.050 |
Why?
|
Receptors, Phospholipase A2 | 1 | 2020 | 33 | 0.050 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2020 | 107 | 0.040 |
Why?
|
United States | 2 | 2017 | 69693 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2023 | 850 | 0.040 |
Why?
|
Africa, Northern | 1 | 2018 | 82 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 270 | 0.040 |
Why?
|
Clathrin | 1 | 2019 | 265 | 0.040 |
Why?
|
Phosphorylation | 2 | 2019 | 8436 | 0.040 |
Why?
|
Lithuania | 1 | 2017 | 13 | 0.040 |
Why?
|
Prospective Studies | 3 | 2017 | 53187 | 0.040 |
Why?
|
Adenosine | 1 | 2022 | 823 | 0.040 |
Why?
|
Exocytosis | 1 | 2019 | 353 | 0.040 |
Why?
|
Histocompatibility Testing | 1 | 2019 | 742 | 0.040 |
Why?
|
Heredity | 1 | 2017 | 154 | 0.040 |
Why?
|
Spain | 1 | 2018 | 465 | 0.040 |
Why?
|
Cell Movement | 2 | 2019 | 5212 | 0.040 |
Why?
|
France | 1 | 2018 | 517 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 5979 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 936 | 0.040 |
Why?
|
Italy | 1 | 2018 | 828 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2017 | 351 | 0.030 |
Why?
|
Embryo, Nonmammalian | 1 | 2019 | 894 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2019 | 1723 | 0.030 |
Why?
|
Uncertainty | 1 | 2020 | 725 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 963 | 0.030 |
Why?
|
Base Composition | 1 | 2015 | 293 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2502 | 0.030 |
Why?
|
Consensus Sequence | 1 | 2015 | 377 | 0.030 |
Why?
|
Birth Weight | 1 | 2023 | 2068 | 0.030 |
Why?
|
Endocytosis | 1 | 2019 | 983 | 0.030 |
Why?
|
Computer Simulation | 2 | 2020 | 6191 | 0.030 |
Why?
|
Genome | 1 | 2022 | 1803 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3199 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 732 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 898 | 0.030 |
Why?
|
Chromosomes, Human, X | 1 | 2015 | 296 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1382 | 0.030 |
Why?
|
Genetic Techniques | 1 | 2016 | 435 | 0.030 |
Why?
|
Protein Transport | 1 | 2019 | 1988 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1777 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2018 | 1342 | 0.030 |
Why?
|
Animals | 6 | 2022 | 168561 | 0.030 |
Why?
|
Mice | 4 | 2022 | 81045 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2015 | 57683 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2790 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2170 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 527 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2384 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2205 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5454 | 0.020 |
Why?
|
Cell Membrane | 1 | 2019 | 3744 | 0.020 |
Why?
|
North America | 1 | 2013 | 1249 | 0.020 |
Why?
|
Systems Biology | 1 | 2013 | 469 | 0.020 |
Why?
|
India | 1 | 2015 | 2187 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13814 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4554 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4282 | 0.020 |
Why?
|
Regeneration | 1 | 2015 | 1485 | 0.020 |
Why?
|
Aged | 2 | 2015 | 162944 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2012 | 1811 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1503 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8541 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10392 | 0.020 |
Why?
|
Infant | 2 | 2017 | 35070 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15994 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 12071 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2019 | 14554 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9735 | 0.010 |
Why?
|
Apoptosis | 1 | 2019 | 9715 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12344 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21821 | 0.010 |
Why?
|
Proteins | 1 | 2015 | 6096 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13853 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19223 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8297 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13256 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20928 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11470 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23320 | 0.010 |
Why?
|
Pregnancy | 1 | 2019 | 29087 | 0.010 |
Why?
|
Registries | 1 | 2013 | 8077 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 13921 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23387 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18355 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 11695 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40054 | 0.010 |
Why?
|
Concepts
(223)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_